



The art of systematic reviews 
 
Author: Arianne Verhagen 
 
Aim 
The general aim of a systematic review is to get an overview of the existing evidence/literature from all 
relevant studies on a specific topic (i.e. review question). Given the increasing amount of research 
information it becomes almost impossible for clinicians to keep up with the published evidence. Also 
synthesising and critically appraise all the evidence becomes impossible for clinicians. Therefore 
systematic reviews aim to help e.g. clinicians (or patients, decision makers etc) to provide them with a 
clear overview of the existing knowledge.  
 
History 
Systematic synthesis of research findings and critical appraisal of the literature in a systematic way was 
first mentioned in 1975 as a 'meta analysis' [Glass and Smith 1979]. Next, the term ‘systematic review’ 
appeared around 1990. The origin of the term can be attributed to a meeting organised by the British 
Medical Journal and the Cochrane Centre in London in 1993 [Chalmers and Altman, 1995]. Here the 
members of this meeting expressed their concern that reviews on clinical treatments lack the use of 
‘scientific principles’ and could therefore be potentially biased or even harmful [Chalmers and Altman, 
1995, Boel 2011]. 
Already in 1972 Archie Cochrane wrote a book in which he urged health care practitioners to practice 
evidence-based medicine [Cochrane 1972]. The term evidence based health care was later defined by 
David Sackett as ‘the conscientious, explicit, judicious use of current best evidence in making decisions 
about the care of individual patients.' [Sackett 1996]. Since than the term ‘systematic review’ has gained 
momentum in being adopted for a state of the art literature review. Systematic reviews of randomized 
controlled trials became key in the practice of evidence-based medicine [Chalmers 1995]. Today 
systematic reviews and meta-analysis (a systematic review where the review authors use statistical 
analysis to combine the results of multiple studies into one effect estimate) are an essential element in 
professional guidelines and guides health care decisions.  
 
Cochrane Collaboration 
In 1992 the Cochrane Collaboration opened its first center in Oxford. Since the launch of the Cochrane 
Collaboration the Cochrane systematic review set the standards of review methodology and still many 
innovative methodologists update the rigorous methodology and statistical analysis to ensure high quality 
systematic reviews and meta-analysis. Today the Cochrane Collaboration is an international network of 
over 37,000 researchers, academics, practitioners and consumers (patients) in over 130 countries, 14 
centers, 53 review groups and 14 methods groups, all committed to the principles of managing healthcare 
knowledge in such a way that it is quality assured, accessible, and cumulative [Cochrane Collaboration]. 
 
Systematic review as study design. 
As the label indicates a systematic review follows a systematic and structured approach in a way that it 
ensures an objective and transparent research synthesis, with the aim of minimizing bias. The formulation 
of the research question is essential and can comprise treatment effectiveness, prognosis, etiology, 
diagnostic strategies etc. A typical formulation of the research question of effectiveness/efficacy studies is 
called the PICO: P for patients/participants, I for the intervention under study, C for control intervention 
as a comparison, O for outcome. Within the Cochrane these outcomes are always patient-related or 
patient-reported outcome measures. An example of a PICO is: “Effectiveness (systematic review of 
(randomized) clinical trials) of spinal manipulative therapy (I) compared to all kinds of control 
interventions (C) for acute low back pain (P) on pain and functioning (O) [Rubinstein 2012]. For other 
research designs the PICO is slightly different, for instance for diagnostic accuracy reviews the P is for 
patients, the I for index test, the C for comparison test or reference test and O for outcome (or diagnosis). 
An example of such a PICO is: “Diagnostic accuracy of physical examination (I) compared to imaging or 
surgery (C) in low back pain patients (P) suspected of lumbar disc herniation (O)” [van der Windt 2010].  
The research question guides a thorough search for all relevant literature. Restriction for languages or 
dates of publications is unusual as it conflicts with the general aim “to get an overview of the existing 
evidence”. Study selection, assessment of the risk of bias (or methodological quality) of the included 
studies, the data extraction and the analysis all follow a strict protocol ensuring optimal transparency and 
a minimal risk of bias. Frequently systematic reviews use statistical techniques (statistical pooling) to 
combine the results of multiple studies, which provide one, more precise, estimate, and than it is called a 
meta-analysis. When a statistical pooling cannot be done due to e.g. clinical heterogeneity of the studies 
(not combining apples and oranges) or the high risk of bias in the individual studies, some systematic 
reviews use a scoring system (levels of evidence) to come to a conclusion instead of a statistical pooling. 
Recently this statistical pooling is followed by a system that determines what the quality of the evidence 
is, meaning how much do we trust that the effect estimate is true. The system to do so is called GRADE 
Grading of Recommendations Assessment, Development, and Evaluation (GRADE) [Gyuatt 2008]. 
 
Systematic reviewing is now a respectable research design, comparable to other research designs such as 
randomized clinical trials or (prospective) cohort studies. First, there is a registry where authors can 
register their protocol of a systematic review (PROSPERO). The aim of this registry is comparable with the 
aim of e.g. registries of randomized clinical trials, namely to avoid duplication, to ensure that reviews are 
executed as planned, prevent outcome reporting bias and that protocol deviations are discussed. Next, the 
quality of the systematic review itself can be assessed with quality appraisal instruments (Amstar, Robis), 
comparable with all quality appraisal instruments for all kinds of other research designs [Shea 2009; 
Whiting 2016]. Finally, reporting guidelines (prisma) ensure that systematic reviews are reported as best 
as possible comparable with reporting guidelines for all kinds of other study designs [www.equator.com].  
 
Strengths 
There are several benefits of systematic reviews. First of all it provides an overview of the existing 
evidence. This implies that researchers ideally should only design new studies (and find money to execute 
these new studies) after evaluating the body of knowledge via systematic reviews. Two of the founding 
fathers of evidence based medicine (Ian Chalmers and Paul Glasziou) therefore posted the term ‘research 
waste’ where the authors argue that research (and money) waste could be avoided if all research was 
preceded by a systematic assessment of the existing evidence [Chalmers 2009, 2014]. In case the evidence 
is clear, new studies should not be executed. This is still not common practice today.  
Secondly, decision makers or health care insurance companies frequently use systematic reviews to 
influence current practice. Some interventions get easily implemented, for instance a Cochrane review 
that showed that act as usual was as effective as bed rest for patients with a suspected lumbar disc 
herniation [Hagen 2000]. The implementation of this change in interventions from bed rest to act as usual 
or exercise happened rather rapidly as apparently patients, care givers and decision makers liked it. On 
the other hand systematic reviews showing that diagnostic imaging in musculoskeletal disorders, more 
specifically low back pain, does not lead to better patient outcomes [Ghou 2009; Karel 2015]. Due to 
various factors, such as patient preferences, difficulty in changing doctors behavior, costs (earnings) this 
finding does not get easily implemented by itself. This is because not preforming diagnostic imaging 
actually involves de-implementation of an intervention in which patients and doctors have high trusts, 
although there are effective de-implementation strategies for this intervention [Jenkins 2015].  
Lastly, publishing a systematic review can boost careers. It can help journals to improve their impact 
factor as high quality systematic reviews are frequently cited. The same holds for the career of a scientist, 
as their careers depend on publications in high impact journals and frequent citations of their publication 
that increase their H-index. In conclusion, performing and publishing systematic reviews is sexy. 
 
Weaknesses 
To be of value systematic reviews need to be as up to date as possible. This increases the risk of 
duplication, which are potentially wasted research efforts. Today for the majority of topics in 
musculoskeletal disorders there is more than one systematic review available. For instance, in the field of 
low back pain various systematic reviews exist evaluating the effectiveness of spinal manipulations. 
Frequently the number of studies included in these reviews varies and so does the conclusion. This 
conflicts with the primary aim, as it does not help clinicians and patients in deciding about clinical 
management. 
Scientists sometimes think a systematic review is a rather easy to do research design, therefore frequently 
systematic reviews lack methodological rigor and quality. For instance, during the development of a neck 
pain guideline for physiotherapists we found four systematic reviews on dry needling [Bier 2017]. All four 
systematic reviews suffered from severe methodological problems, as twell as their conclusions in the 
abstract were much more positive for dry needling as the actual conclusiosns in the main text of the 
publication. Therefore we searched for relevant trials within these systematic reviews that answered our 
study question in the guideline.  
 
Already in 2007 a study found that of 100 systematic reviews monitored, 7% needed updating at the time 
of publication, another 4% within a year, and another 11% within 2 years; this figure was higher in 
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